2-[(2R)-6,6-dimethyl-3-oxo-4-[1-[6-(trifluoromethyl)pyridazin-4-yl]pyrazol-3-yl]morpholin-2-yl]-2-hydroxyacetic acid
C16H16F3N5O5 — CID 90241889
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(2R)-6,6-dimethyl-3-oxo-4-[1-[6-(trifluoromethyl)pyridazin-4-yl]pyrazol-3-yl]morpholin-2-yl]-2-hydroxyacetic acid
2-[(2R)-6,6-dimethyl-3-oxo-4-[1-[6-(trifluoromethyl)pyridazin-4-yl]pyrazol-3-yl]morpholin-2-yl]-2-hydroxyacetic acid (PubChem CID 90241889) has the molecular formula C16H16F3N5O5 and a molecular weight of 415.33 g/mol. Its IUPAC name is 2-[(2R)-6,6-dimethyl-3-oxo-4-[1-[6-(trifluoromethyl)pyridazin-4-yl]pyrazol-3-yl]morpholin-2-yl]-2-hydroxyacetic acid.
Molecular Properties
| Compound Name | 2-[(2R)-6,6-dimethyl-3-oxo-4-[1-[6-(trifluoromethyl)pyridazin-4-yl]pyrazol-3-yl]morpholin-2-yl]-2-hydroxyacetic acid |
|---|---|
| PubChem CID | 90241889 |
| Molecular Formula | C16H16F3N5O5 |
| Molecular Weight | 415.33 g/mol |
| Exact Mass | 415.11 |
| IUPAC Name | 2-[(2R)-6,6-dimethyl-3-oxo-4-[1-[6-(trifluoromethyl)pyridazin-4-yl]pyrazol-3-yl]morpholin-2-yl]-2-hydroxyacetic acid |
| SMILES | CC1(C)CN(c2ccn(-c3cnnc(C(F)(F)F)c3)n2)C(=O)[C@@H](C(O)C(=O)O)O1 |
| InChI | InChI=1S/C16H16F3N5O5/c1-15(2)7-23(13(26)12(29-15)11(25)14(27)28)10-3-4-24(22-10)8-5-9(16(17,18)19)21-20-6-8/h3-6,11-12,25H,7H2,1-2H3,(H,27,28)/t11?,12-/m1/s1 |
| InChIKey | WGGLFCPOUSANHS-PIJUOVFKSA-N |
| XLogP | 0.64 |
| TPSA | 130.67 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 415.33 |
| LogP ≤ 5 | 0.64 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90241889 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.